Evidence map›Paper›PMID 25271282›Full record

ArticlemBio2014

A comprehensive functional map of the hepatitis C virus genome provides a resource for probing viral proteins.

Roland Remenyi, Hangfei Qi, Sheng-Yao Su, Zugen Chen, Nicholas C Wu, Vaithilingaraja Arumugaswami, Shawna Truong, Virginia Chu, Tamar Stokelman, Hung-Hao Lo and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Roland RemenyiDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA.
Hangfei QiDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA.
Sheng-Yao Su
Zugen ChenDepartment of Human Genetics, University of California Los Angeles, Los Angeles, California, USA.
Nicholas C WuThe Molecular Biology Institute, University of California Los Angeles, Los Angeles, California, USA.
Vaithilingaraja Arumugaswami
Shawna TruongDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, USA.
Virginia ChuDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, USA.
Tamar StokelmanDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, USA.
Hung-Hao LoInstitute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan.
C Anders OlsonDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA.
Ting-Ting WuDepartment of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA.
Shu-Hwa ChenInstitute of Information Science, Academia Sinica, Taipei, Taiwan.
Chung-Yen LinInstitute of Information Science, Academia Sinica, Taipei, Taiwan.
Ren Sunrsun@mednet.ucla.edu.
University of California, Los Angeles · USInstitute of Information Science, Academia Sinica · TWNational Yang Ming Chiao Tung University · TWNational Yang Ming Chiao Tung University · TW

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Quantitative High-Resolution Genetic Profiling of a GammaherpesvirusR21AI078133 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2010 to 2011
$422k
Functional Profiles of Hepatitis C Virus Genome at Single Nucleotide ResolutionR21CA183615 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2014 to 2015
$368k
NCI NIH HHS P30 CA016042NCI NIH HHS P30CA016042NCI NIH HHS R21 CA183615NIAID NIH HHS AI078133NIAID NIH HHS P30 AI028697NIAID NIH HHS P30AI028697NIAID NIH HHS R21 AI078133
6 · The paper itself

Abstract

unlabelledPairing high-throughput sequencing technologies with high-throughput mutagenesis enables genome-wide investigations of pathogenic organisms. Knowledge of the specific functions of protein domains encoded by the genome of the hepatitis C virus (HCV), a major human pathogen that contributes to liver disease worldwide, remains limited to insight from small-scale studies. To enhance the capabilities of HCV researchers, we have obtained a high-resolution functional map of the entire viral genome by combining transposon-based insertional mutagenesis with next-generation sequencing. We generated a library of 8,398 mutagenized HCV clones, each containing one 15-nucleotide sequence inserted at a unique genomic position. We passaged this library in hepatic cells, recovered virus pools, and simultaneously assayed the abundance of mutant viruses in each pool by next-generation sequencing. To illustrate the validity of the functional profile, we compared the genetic footprints of viral proteins with previously solved protein structures. Moreover, we show the utility of these genetic footprints in the identification of candidate regions for epitope tag insertion. In a second application, we screened the genetic footprints for phenotypes that reflected defects in later steps of the viral life cycle. We confirmed that viruses with insertions in a region of the nonstructural protein NS4B had a defect in infectivity while maintaining genome replication. Overall, our genome-wide HCV mutant library and the genetic footprints obtained by high-resolution profiling represent valuable new resources for the research community that can direct the attention of investigators toward unidentified roles of individual protein domains. IMPORTANCE: Our insertional mutagenesis library provides a resource that illustrates the effects of relatively small insertions on local protein structure and HCV viability. We have also generated complementary resources, including a website (http://hangfei.bol.ucla.edu) and a panel of epitope-tagged mutant viruses that should enhance the research capabilities of investigators studying HCV. Researchers can now detect epitope-tagged viral proteins by established antibodies, which will allow biochemical studies of HCV proteins for which antibodies are not readily available. Furthermore, researchers can now quickly look up genotype-phenotype relationships and base further mechanistic studies on the residue-by-residue information from the functional profile. More broadly, this approach offers a general strategy for the systematic functional characterization of viruses on the genome scale.

Indexed as

Genome, ViralCell LineChromosome MappingCloning, MolecularDNA Transposable ElementsDNA, ViralGene LibraryHepacivirusHigh-Throughput Nucleotide SequencingHumansMutagenesis, InsertionalPlasmidsSequence Analysis, DNATranscription, GeneticTransfectionViral ProteinsDNA Transposable ElementsDNA, ViralViral Proteins

Identifiers

PMID25271282
PMCPMC4196222
OpenAlexW2113706767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.